🇺🇸 FDA
Company

Caribou

Caribou Biosciences

CRBU biotech USA

Quick answer

Caribou is a biotech company (CRBU) headquartered in BERKELEY, CA, USA with 4 tracked pipeline programs.

Pipeline (4)

project

CB-010

Lymphoma, Non-Hodgkin

Phase 1 · gene_therapy · active

1 trials project

CB-010

Systemic Lupus Erythematosus

Phase 1 · small_molecule · terminated

1 trials project

CB-011

Relapsed/Refractory Multiple Myeloma

Phase 1 · mab · active

1 trials project

CB-012

Acute Myeloid Leukemia, in Relapse

Phase 1 · small_molecule · terminated

1 trials

Patents (8)

patent

US 11939604

Modified cascade ribonucleoproteins and uses thereof

Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11932703

Anti-ROR1 antibody and ROR1-targeting engineered cells

Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11472884

Humanized BCMA antibody and BCMA-CAR-T cells

Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11312953

Compositions and methods of nucleic acid-targeting nucleic acids

Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11299549

Humanized BCMA antibody and BCMA-CAR-T cells

Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11142583

BCMA-CAR-natural killer (NK) cells and methods related thereto

Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11021542

Humanized BCMA antibody and BCMA-CAR-T cells

Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10954498

Modified cascade ribonucleoproteins and uses thereof

Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)